FG Xpress PowerStrip on FDA’s Medical Device List

July 11, 2013
FG Xpress PowerStrip on FDA’s Medical Device List
ForeverGreen Worldwide Corporation (FVRG), a leading provider of nutritional foods and other healthy products, today announced the company had received FDA listing as a Class 1 Medical device useful as a pain relief product. Allen Davis, General Counsel, stated, “ForeverGreen, in cooperation with the manufacturer of its PowerStrips product, has completed the tedious, time consuming and expensive process of listing PowerStrips on the FDA medical device list. As a listed Class 1 medical device, the FGX PowerStrips are unique. By focusing heat and energy to the areas where they are applied, PowerStrips can bring relief of pain and discomfort. This is a major differentiator between our PowerStrip patch and nearly all others on the market. This is easily one of the larger milestones we have achieved at ForeverGreen.”

ForeverGreen Worldwide Corporation develops, manufactures and distributes an expansive line of all natural whole foods and products to North America, Australia, Europe, Asia and South America. Offerings include their new global offering, Power Strips. Additionally, they offer Azul and FrequenSea™ whole-food beverages with industry exclusive Marine Phytoplankton, Versativa line of hemp-based whole-food products, A.I.M. Transfer Factor immune support, 03World™ weight management products, Pulse-8 powdered L-arginine formula, TRUessence™ Essential Oils and Apothecary, 24Karat Chocolate®, and an entire catalog of meals, snacks, household cleaners and personal care products. www.forevergreen.org

Forward-Looking Statement
This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are “forward-looking statements” and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include among others, certain risks associated with the operation of the company described above. The company’s actual results could differ materially from expected results.